Showing 1 - 5 results of 5 for search 'Henk J G Bilo', query time: 0.02s
Refine Results
-
1
-
2
Identifying and delineating the type 2 diabetes population in the Netherlands using an all-payer claims database: characteristics, healthcare utilisation and expenditures by Dirk Ruwaard, Henk J G Bilo, Rose J Geurten, Arianne M J Elissen, Jeroen N Struijs, Chantal van Tilburg
Published 2021-12-01Get full text
Article -
3
Demographical, Clinical, and Psychological Characteristics of Users and Nonusers of an Online Platform for T2DM Patients (e-VitaDM-3/ZODIAC-44) by Yvonne Roelofsen, Michael van Vugt, Steven H. Hendriks, Kornelis J. J. van Hateren, Klaas H. Groenier, Frank J. Snoek, Nanne Kleefstra, Robbert Huijsman, Henk J. G. Bilo
Published 2016-01-01Get full text
Article -
4
Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials. by Gijs W D Landman, Geertruide H de Bock, Kornelis J J van Hateren, Peter R van Dijk, Klaas H Groenier, Rijk O B Gans, Sebastiaan T Houweling, Henk J G Bilo, Nanne Kleefstra
Published 2014-01-01Get full text
Article -
5
Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28). by Esther G Gerrits, Alaa Alkhalaf, Gijs W D Landman, Kornelis J J van Hateren, Klaas H Groenier, Joachim Struck, Janin Schulte, Reinold O B Gans, Stephan J L Bakker, Nanne Kleefstra, Henk J G Bilo
Published 2014-01-01Get full text
Article